Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1019

1.

Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression.

Kautzky A, James GM, Philippe C, Baldinger-Melich P, Kraus C, Kranz GS, Vanicek T, Gryglewski G, Hartmann AM, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R.

Transl Psychiatry. 2019 Jan 16;9(1):5. doi: 10.1038/s41398-018-0308-2.

PMID:
30664620
2.

β6 -Integrin serves as a novel serum tumor marker for colorectal carcinoma.

Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M.

Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32137. [Epub ahead of print]

PMID:
30653264
3.

[Immuno-oncology of head and neck tumors].

Kasper S, Hussain T, Virchow I, Stuschke M, Lang S.

HNO. 2019 Jan 11. doi: 10.1007/s00106-018-0602-6. [Epub ahead of print] German.

PMID:
30635676
4.

The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography.

Baldinger-Melich P, Gryglewski G, Philippe C, James GM, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J, Kranz GS, Hahn A, Winkler D, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Frey R, Lanzenberger R.

Brain Stimul. 2019 Jan 2. pii: S1935-861X(18)31395-0. doi: 10.1016/j.brs.2018.12.976. [Epub ahead of print]

PMID:
30635228
5.

Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.

Vummidi Giridhar P, Williams K, VonHandorf AP, Deford PL, Kasper S.

Cancer Res. 2019 Jan 9. pii: canres.1753.2018. doi: 10.1158/0008-5472.CAN-18-1753. [Epub ahead of print]

PMID:
30626627
6.

Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI.

Kautzky A, Seiger R, Hahn A, Fischer P, Krampla W, Kasper S, Kovacs GG, Lanzenberger R.

Front Aging Neurosci. 2018 Dec 10;10:406. doi: 10.3389/fnagi.2018.00406. eCollection 2018.

7.

Bio-absorbable sealants for reinforcing the pancreatic stump after distal pancreatectomy are critical.

Kühlbrey CM, Kasper S, Chikhladze S, Seifert G, Hopt UT, Fichtner-Feigl S, Wittel UA.

J Hepatobiliary Pancreat Sci. 2018 Dec 27. doi: 10.1002/jhbp.604. [Epub ahead of print]

PMID:
30589508
8.

Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer.

Wiesweg M, Kasper S, Worm K, Herold T, Reis H, Sara L, Metzenmacher M, Abendroth A, Darwiche K, Aigner C, Wedemeyer HH, Helfritz FA, Stuschke M, Schumacher B, Markus P, Paul A, Rahmann S, Schmid KW, Schuler M.

Oncogene. 2018 Dec 19. doi: 10.1038/s41388-018-0634-0. [Epub ahead of print]

PMID:
30568222
9.

Pathoanatomy of Maisonneuve fracture based on radiologic and CT examination.

Bartoníček J, Rammelt S, Kašper Š, Malík J, Tuček M.

Arch Orthop Trauma Surg. 2018 Dec 14. doi: 10.1007/s00402-018-3099-2. [Epub ahead of print]

PMID:
30552509
10.

Making Sense of Connectivity.

Hahn A, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2018 Dec 13. doi: 10.1093/ijnp/pyy100. [Epub ahead of print]

PMID:
30544240
11.

WFSBP guidelines on how to grade treatment evidence for clinical guideline development.

Hasan A, Bandelow B, Yatham LN, Berk M, Falkai P, Möller HJ, Kasper S; WFSBP Guideline Task Force Chairs.

World J Biol Psychiatry. 2018 Dec 11:1-28. doi: 10.1080/15622975.2018.1557346. [Epub ahead of print]

PMID:
30526182
12.

Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.

Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA.

Br J Psychiatry. 2019 Jan;214(1):27-35. doi: 10.1192/bjp.2018.257. Epub 2018 Dec 6.

PMID:
30520709
13.

Implementing prevention of seasonal affective disorder from patients' and physicians' perspectives - a qualitative study.

Nussbaumer-Streit B, Pjrek E, Kien C, Gartlehner G, Bartova L, Friedrich ME, Kasper S, Winkler D.

BMC Psychiatry. 2018 Nov 26;18(1):372. doi: 10.1186/s12888-018-1951-0.

14.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.

Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, Serretti A.

Br J Psychiatry. 2019 Jan;214(1):36-41. doi: 10.1192/bjp.2018.256. Epub 2018 Nov 23.

PMID:
30468137
15.

Corrigendum to "Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging".

Gryglewski G, Seiger R, James GM, Godbersen GM, Komorowski A, Unterholzner J, Michenthaler P, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R.

Neuroimage. 2018 Nov 19. pii: S1053-8119(18)32062-7. doi: 10.1016/j.neuroimage.2018.10.081. [Epub ahead of print] No abstract available.

PMID:
30467081
16.

Updated European Consensus Statement on diagnosis and treatment of adult ADHD.

Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, Thome J, Dom G, Kasper S, Nunes Filipe C, Stes S, Mohr P, Leppämäki S, Casas Brugué M, Bobes J, Mccarthy JM, Richarte V, Kjems Philipsen A, Pehlivanidis A, Niemela A, Styr B, Semerci B, Bolea-Alamanac B, Edvinsson D, Baeyens D, Wynchank D, Sobanski E, Philipsen A, McNicholas F, Caci H, Mihailescu I, Manor I, Dobrescu I, Saito T, Krause J, Fayyad J, Ramos-Quiroga JA, Foeken K, Rad F, Adamou M, Ohlmeier M, Fitzgerald M, Gill M, Lensing M, Motavalli Mukaddes N, Brudkiewicz P, Gustafsson P, Tani P, Oswald P, Carpentier PJ, De Rossi P, Delorme R, Markovska Simoska S, Pallanti S, Young S, Bejerot S, Lehtonen T, Kustow J, Müller-Sedgwick U, Hirvikoski T, Pironti V, Ginsberg Y, Félegyházy Z, Garcia-Portilla MP, Asherson P.

Eur Psychiatry. 2018 Nov 16;56:14-34. doi: 10.1016/j.eurpsy.2018.11.001. [Epub ahead of print]

17.

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.

Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S.

Eur Neuropsychopharmacol. 2018 Dec;28(12):1305-1313. doi: 10.1016/j.euroneuro.2018.10.003. Epub 2018 Nov 13.

PMID:
30446357
18.

Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.

Kasper S, Kisro J, Fuchs M, Müller C, Schulz-Abelius A, Karthaus M, Rafiyan MR, Stein A.

BMC Cancer. 2018 Nov 16;18(1):1124. doi: 10.1186/s12885-018-5063-5.

19.

Definition of treatment-resistant depression - Asia Pacific perspectives.

Ng CH, Kato T, Han C, Wang G, Trivedi M, Ramesh V, Shao D, Gala S, Narayanan S, Tan W, Feng Y, Kasper S.

J Affect Disord. 2018 Nov 5;245:626-636. doi: 10.1016/j.jad.2018.11.038. [Epub ahead of print] Review.

20.

Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis.

Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen GM, Michenthaler P, Klöbl M, Spurny B, Kautzky A, Vanicek T, Kasper S, Frey R, Lanzenberger R.

Br J Psychiatry. 2018 Nov 16:1-9. doi: 10.1192/bjp.2018.224. [Epub ahead of print]

PMID:
30442205
21.

Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols.

Abendroth A, Noureddine R, Abramczyk M, Paul A, Gerken G, Schmid KW, Markus P, Schumacher B, Wiesweg M, Köhler J, Markus M, Mende B, Dechêne A, Schuler M, Kasper S.

J Cancer Res Clin Oncol. 2018 Nov 14. doi: 10.1007/s00432-018-2789-z. [Epub ahead of print]

PMID:
30430229
22.

The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.

Calabrò M, Fabbri C, Crisafulli C, Albani D, Forloni G, Kasper S, Sidoti A, Velardi E, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Hum Psychopharmacol. 2018 Nov;33(6):e2682. doi: 10.1002/hup.2682. Epub 2018 Nov 13. No abstract available.

PMID:
30426571
23.

Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.

Greil W, Zhang X, Stassen H, Grohmann R, Bridler R, Hasler G, Toto S, Bleich S, Kasper S.

Eur Neuropsychopharmacol. 2018 Nov 10. pii: S0924-977X(18)30845-9. doi: 10.1016/j.euroneuro.2018.10.010. [Epub ahead of print]

24.

Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo.

James GM, Gryglewski G, Vanicek T, Berroterán-Infante N, Philippe C, Kautzky A, Nics L, Vraka C, Godbersen GM, Unterholzner J, Sigurdardottir HL, Spies M, Seiger R, Kranz GS, Hahn A, Mitterhauser M, Wadsak W, Bauer A, Hacker M, Kasper S, Lanzenberger R.

Cereb Cortex. 2019 Jan 1;29(1):372-382. doi: 10.1093/cercor/bhy249.

25.

Knee Extensors Muscle Plasticity Over a 5-Years Rehabilitation Process After Open Knee Surgery.

Flück M, Viecelli C, Bapst AM, Kasper S, Valdivieso P, Franchi MV, Ruoss S, Lüthi JM, Bühler M, Claassen H, Hoppeler H, Gerber C.

Front Physiol. 2018 Sep 25;9:1343. doi: 10.3389/fphys.2018.01343. eCollection 2018.

26.

Opinion paper: poor response to treatment of depression in people in high occupational levels.

Mandelli L, Serretti A, Porcelli S, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J.

Psychol Med. 2019 Jan;49(1):49-54. doi: 10.1017/S003329171800288X. Epub 2018 Oct 12.

PMID:
30311597
27.

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Kautzky A, Dold M, Bartova L, Spies M, Kranz GS, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S.

Acta Psychiatr Scand. 2019 Jan;139(1):78-88. doi: 10.1111/acps.12959. Epub 2018 Oct 5.

PMID:
30291625
28.

Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy.

Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, Komorowski A, Kautzky A, Silberbauer L, Pichler V, Kranz GS, Nics L, Balber T, Baldinger-Melich P, Vanicek T, Spurny B, Winkler-Pjrek E, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R, Winkler D.

Transl Psychiatry. 2018 Sep 21;8(1):198. doi: 10.1038/s41398-018-0227-2.

29.

Circuit mechanisms of reward, anhedonia and depression.

Höflich A, Michenthaler P, Kasper S, Lanzenberger R.

Int J Neuropsychopharmacol. 2018 Sep 15. doi: 10.1093/ijnp/pyy081. [Epub ahead of print]

PMID:
30239748
30.

Editorial.

Kasper S.

World J Biol Psychiatry. 2018 Sep;19(6):411. doi: 10.1080/15622975.2018.1499274. No abstract available.

PMID:
30175952
31.

Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression.

Benedetti F, Avery DH, Bauer M, Bunney WE, Çaliyurt O, Camardese G, Colombo C, Dallaspezia S, Henriksen TE, Kasper S, Kuriyama K, Lam RW, Martiny K, Meesters Y, Mishima K, Schulte R, Suzuki M, Święcicki Ł, Uchiyama M, Veale D, Winkler D, Wu J, Kupeli NY, Yoshiike T, Yu X.

Am J Psychiatry. 2018 Sep 1;175(9):905-906. doi: 10.1176/appi.ajp.2018.18020231. No abstract available.

PMID:
30173556
32.

Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study.

Fountoulakis KN, Karavelas V, Moysidou S, Mavridis D, Pastiadis K, Petalidou N, Nimatoudis I, Kasper S.

Pharmacopsychiatry. 2018 Aug 31. doi: 10.1055/a-0695-9223. [Epub ahead of print]

PMID:
30170329
33.

Striatal dopaminergic alterations in Tourette's syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies.

Hienert M, Gryglewski G, Stamenkovic M, Kasper S, Lanzenberger R.

Transl Psychiatry. 2018 Aug 2;8(1):143. doi: 10.1038/s41398-018-0202-y.

34.

Editorial.

Kasper S.

Int J Psychiatry Clin Pract. 2018 Sep;22(3):163. doi: 10.1080/13651501.2018.1485264. No abstract available.

PMID:
30067153
35.

Rapid antidepressant effect of S-ketamine in schizophrenia.

Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S.

Eur Neuropsychopharmacol. 2018 Aug;28(8):980-982. doi: 10.1016/j.euroneuro.2018.05.007. Epub 2018 Jul 2.

PMID:
30041987
36.

Diversity matters: combinatorial information coding by GABAA receptor subunits during spatial learning and its allosteric modulation.

Szodorai E, Bampali K, Romanov RA, Kasper S, Hökfelt T, Ernst M, Lubec G, Harkany T.

Cell Signal. 2018 Oct;50:142-159. doi: 10.1016/j.cellsig.2018.07.003. Epub 2018 Jul 11. Review.

PMID:
30006122
37.

Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI.

Rischka L, Gryglewski G, Pfaff S, Vanicek T, Hienert M, Klöbl M, Hartenbach M, Haug A, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R, Hahn A.

Neuroimage. 2018 Nov 1;181:323-330. doi: 10.1016/j.neuroimage.2018.06.079. Epub 2018 Jun 30.

PMID:
29966719
38.

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093/ijnp/pyy048.

39.

Editorial.

Kasper S.

World J Biol Psychiatry. 2018 Aug;19(5):329. doi: 10.1080/15622975.2018.1485832. No abstract available.

PMID:
29938569
40.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F.

Pharmacol Rev. 2018 Jul;70(3):475-504. doi: 10.1124/pr.117.014977. Review.

PMID:
29884653
41.

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, Kiyota N, Tahara M, Lynch M, Jayaprakash V, Li L, Gillison ML.

Oral Oncol. 2018 Jun;81:45-51. doi: 10.1016/j.oraloncology.2018.04.008. Epub 2018 Apr 17.

PMID:
29884413
42.

CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.

Gillison ML, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Li L, Ferris RL.

Oncologist. 2018 Sep;23(9):1079-1082. doi: 10.1634/theoncologist.2017-0674. Epub 2018 Jun 4.

PMID:
29866947
43.

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou GN, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009.

44.

Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma.

Juntermanns B, Kaiser GM, Orth L, Reis H, Jaradat D, Sydor S, Buechter M, Kasper S, Mathé Z, Sotiropoulos GC, Baba HA, Canbay A, Paul A, Fingas CD.

Eur J Med Res. 2018 Jun 1;23(1):29. doi: 10.1186/s40001-018-0329-6.

45.

Usage of Therapeutic Sleep Deprivation: A Survey in Psychiatric Hospitals in Austria, Germany, and Switzerland.

Winkler D, Spies M, Al-Resheg Y, Wu JC, Bunney WE, Bunney BG, Kasper S, Pjrek E.

Behav Sleep Med. 2018 May 18:1-8. doi: 10.1080/15402002.2018.1469494. [Epub ahead of print]

PMID:
29775085
46.

Personalised and precision psychiatry: what do the CINP bipolar guidelines suggest?

Fountoulakis KN, Moeller HJ, Kasper S.

Int J Psychiatry Clin Pract. 2018 May 15:1-2. doi: 10.1080/13651501.2018.1470246. [Epub ahead of print] No abstract available.

PMID:
29764259
47.

Influence of CRHR1 Polymorphisms and Childhood Abuse on Suicide Attempts in Affective Disorders: A GxE Approach.

Ludwig B, Kienesberger K, Carlberg L, Swoboda P, Bernegger A, Koller R, Wang Q, Inaner M, Zotter M, Kapusta ND, Haslacher H, Aigner M, Kasper S, Schosser A.

Front Psychiatry. 2018 Apr 26;9:165. doi: 10.3389/fpsyt.2018.00165. eCollection 2018.

48.

Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging.

Gryglewski G, Seiger R, James GM, Godbersen GM, Komorowski A, Unterholzner J, Michenthaler P, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R.

Neuroimage. 2018 Aug 1;176:259-267. doi: 10.1016/j.neuroimage.2018.04.068. Epub 2018 May 1. Erratum in: Neuroimage. 2018 Nov 19;:.

PMID:
29723639
49.

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Eur Neuropsychopharmacol. 2018 Jun;28(6):752-760. doi: 10.1016/j.euroneuro.2018.03.011. Epub 2018 Apr 26.

PMID:
29705022
50.

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives.

Fabbri C, Corponi F, Souery D, Kasper S, Montgomery S, Zohar J, Rujescu D, Mendlewicz J, Serretti A.

Int J Neuropsychopharmacol. 2018 Apr 21. doi: 10.1093/ijnp/pyy024. [Epub ahead of print]

PMID:
29688548

Supplemental Content

Loading ...
Support Center